Stx2A-LHRH重组毒素对HeLa细胞毒性作用的探讨
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2003年第6期440-442,共3页
Chinese Journal of Clinical Oncology
二级参考文献14
-
1Kakar SS, Grizzle WE, Neill JD. The nucleotide sequences of human GnRH receptors in breast and ovarin tumors are identical with that found in pituitary[J]. Mol Cell Endocrinol, 1994, 106:145-149.
-
2Imai A, Ohno T, Iida K, et al. Gonadotropin-releasing hormone receptor in gynecologic tumors[J]. Cancer, 1994, 74(9):2555-2561.
-
3Kismanovic LZ, Stojilkovic SS, Mertz LM, et al. Expression of gonadotropin-releasing hormone receptors and autocrine regulation of neuropeptide release in immortalized hypothalamic neurons[J]. Proc Natl Acad Sci USA, 1993, 90:3908-3912.
-
4Kakar SS, Jennes L. Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non-reproductive human tissues[J]. Cancer lett, 1995, 98:57-62.
-
5Pati D, Habibi HR. Inhibition of human hepatocarcinoma cell proliferation by mammalian and fish gonadotropin-releasing hormones[J]. Endocrinology, 1995, 136(1):75-84.
-
6Qayum A, Gullick W, Clayton RC, et al. The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors[J]. Br J Cancer, 1990, 62:96-99.
-
7Yano T ,Korkut E, Pinski J, et al. Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LH-RH[J]. Breast Cancer Res Treat, 1992, 21:35-45.
-
8Emons G, Schally AV. The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers[J]. Hum Reprod, 1994,9:1364-1379.
-
9Srkalovic G, Schally AV, Wittliff JL, et al. Presence and characteristic of receptors for [D-Trp6] luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer[J]. Int J Oncol, 1998, 12:489-498.
-
10Yano T, Pinski J, Radulovic S , et al. Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone[J]. Proc Natl Acad Sci USA, 1994,91:1701-1705.
共引文献20
-
1邓欣,吴广谋,张国利,李树民,孙春华,石丽学,王姿,朱平.LHRH-PE40与Hela细胞表面LHRH受体结合的特异性及其细胞毒性[J].中国医科大学学报,2005,34(2):107-110. 被引量：5
-
2刘华,黄霖,刘晓蔼,杨辉,张薇,刘煜德.乳腺增生大鼠GnRH-R蛋白的表达及健乳灵对其影响[J].医药世界,2006(5):60-62. 被引量：1
-
3姜洋,宋燕,张颖超,吴广谋,张国利,朱平.LHRH-PE40对人结肠癌细胞增殖抑制和凋亡的影响[J].吉林大学学报（医学版）,2006,32(4):647-650. 被引量：2
-
4宋燕,王凌燕,姜洋,高宇飞,吴广谋,朱平.LHRH-PE40对胃癌细胞增殖抑制和诱导凋亡的实验研究[J].中国老年学杂志,2006,26(7):928-929. 被引量：3
-
5黄霖,刘华,杨辉,刘利东,叶振宇,刘晓蔼,张薇,刘煜德.健乳灵对乳腺增生大鼠GnRH及其受体mRNA表达的影响[J].中国中医急症,2006,15(9):1016-1017. 被引量：8
-
6张国利,何畅,吴广谋,岳玉环,朱平.冻干重组人促黄体激素释放激素-绿脓杆菌外毒素A融合蛋白与不同细胞受体结合竞争试验[J].中国实验诊断学,2007,11(5):583-587. 被引量：3
-
7王绍海,朱晓武,王泽华.雌二醇对宫颈癌细胞基质金属蛋白酶2和9表达的影响[J].肿瘤学杂志,2008,14(2):109-112. 被引量：3
-
8张慧瑛,张玉静,胡薇,明宇,张蕾,郝军元.PTD融合蛋白的原核表达及其抗体制备[J].生物技术,2008,18(4):20-22.
-
9张鸿,邓欣,张国利.LHRH-PE40对非小细胞肺癌细胞A549的作用[J].解剖科学进展,2010,16(3):261-263. 被引量：4
-
10邓欣,刘莹,张国利,朱平,宋阳.LHRH-PE40对黑色素瘤A375细胞的诱导凋亡作用[J].中国生物制品学杂志,2011,24(1):37-40. 被引量：3
-
1Pastan I,汪晓梅.重组毒素治疗癌症[J].国外医学（肿瘤学分册）,1992,19(6):349-351.
-
2陈红清.肿瘤治疗的新途径—重组毒素[J].生命的化学,1992,12(5):21-22.
-
3岳瑛,于晓伟,岳玉环,冯书章,朱平,李荷莲,乐杰.志贺毒素2A-促黄体生成素释放激素重组毒素的构建、表达及其意义[J].中华妇产科杂志,2003,38(3):154-157.
-
4周维国,倪鑫,黄志刚,房居高,韩德民,朱冬冬,董震,杨占泉.重组毒素MSH-Ang对喉癌Hep-2细胞的毒性作用研究[J].临床耳鼻咽喉头颈外科杂志,2009,23(5):225-226.
-
5徐渊,吴斌,江岳方.奥曲肽对人前列腺癌细胞株增殖与凋亡的影响[J].江苏医药,2014,40(19):2251-2253. 被引量：1
-
6朱海兵,黄轶,曾昭淳.F3重组毒素的克隆表达及纯化[J].科技导报,2009,27(12):19-22. 被引量：2
-
7任晓燕,孟锐奇,张欣欣,朱冬冬,朱平,董震,杨占泉.EGF-PE4O重组毒素对喉鳞癌细胞株Hep-2的毒性作用[J].耳鼻咽喉（头颈外科）,1999,6(6):356-359. 被引量：1
-
8周维国,赵丽波,朱冬冬,杨占泉.重组表达质粒MSH-Ang的构建[J].临床肿瘤学杂志,2006,11(7):527-529.
-
9张美花,金海丹,朴俊杰,林贞花,金铁峰.曲古抑菌素A体内外杀伤卵巢癌细胞[J].基础医学与临床,2013,33(9):1129-1134. 被引量：1
-
10孙茂本,郭坤元,胡亮杉,邓兰,李玉华,宋朝阳,贺艳杰,陈君.和厚朴酚诱导人急性髓性白血病KG1a细胞凋亡[J].中国肿瘤生物治疗杂志,2011,18(2):160-164. 被引量：8
